Cancer Research | Penn Today

The Washington Post

Ovarian cancer test may not work on some Black, Native American patients

Research from the Perelman School of Medicine indicates that a common test for ovarian cancer may be less effective on Black and Native American patients.

Healio

Clinician nudge at suspected ovarian cancer diagnosis improves oncology referral rate

A study by Anna Jo Smith of the Perelman School of Medicine and colleagues found that a clinician nudge for referral to a gynecologic oncologist at the time of a suspected ovarian cancer diagnosis improved referral rates by 20%.

Oblong-shaped terminals and wall art portraying the workings of the brain.

Brain power on display at the Franklin Institute

Several researchers from Penn Medicine’s Department of Neurology are featured throughout the Franklin Institute’s Body Odyssey exhibit.

1 min. read

Four Penn cancer researchers elected as Fellows of the AACR Academy

Penn Medicine’s Garrett M. Brodeur, Susan Domchek, Stephan Grupp, and Robert Vonderheide have been elected to the 2025 class of Fellows of the American Association for Cancer Research Academy for their contributions in the fight against cancer.

Science News

A child who got CAR-T cancer therapy is still disease-free 18 years later

Carl June of the Perelman School of Medicine says that neuroblastoma is the first solid tumor for which there could be curative effects with CAR T cells.

The Hill

The U.S. is losing its next generation of health scientists

In a co-written opinion essay, James Alwine of the Perelman School of Medicine says that slashing of research funding for NIH and the National Science Foundation will eliminate the next generation of health scientists.

Person with stethoscope using a smartphone.

Text message tool addresses ‘time toxicity’ for cancer patients

In pilot study from Penn Medicine, patients saved over an hour of time at every treatment visit using digital technology.

Person in gloves holding a medical bag of liquids.

No evidence that CAR T cell therapy causes secondary cancers

In a new study, researchers at Penn Medicine looked for—and did not find—examples where the process of generating CAR T cells caused malignancy.

From left, research coordinator Nicolas Sarmiento, project manager Reenie Martins, research coordinator Lee Dengel, and trial sample coordinator Rutendo Manyeka in a hospital.

The compassionate team behind CAR T cancer breakthroughs

The clinical trial support staff at Penn Medicine and the Abramson Cancer Center have helped execute the team science that brings research discoveries from the lab bench to the bedside.

3D rendering of cells on a blue backdrop

New ways to modulate cell activity remotely

Penn researchers use temperature to guide cellular behavior, promising better diagnostics and targeted therapies.

Filters